These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 8181807)
1. Immunohistochemical localization of transforming growth factor-beta 1 in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung disorders. Corrin B; Butcher D; McAnulty BJ; Dubois RM; Black CM; Laurent GJ; Harrison NK Histopathology; 1994 Feb; 24(2):145-50. PubMed ID: 8181807 [TBL] [Abstract][Full Text] [Related]
2. Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a quantitative study of open lung biopsies. Majumdar S; Li D; Ansari T; Pantelidis P; Black CM; Gizycki M; du Bois RM; Jeffery PK Eur Respir J; 1999 Aug; 14(2):251-7. PubMed ID: 10515397 [TBL] [Abstract][Full Text] [Related]
3. Structural features of interstitial lung disease in systemic sclerosis. Harrison NK; Myers AR; Corrin B; Soosay G; Dewar A; Black CM; Du Bois RM; Turner-Warwick M Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):706-13. PubMed ID: 1892314 [TBL] [Abstract][Full Text] [Related]
4. Fibrosing alveolitis in systemic sclerosis: increase in memory T-cells in lung interstitium. Wells AU; Lorimer S; Majumdar S; Harrison NK; Corrin B; Black CM; Jeffery PK; du Bois RM Eur Respir J; 1995 Feb; 8(2):266-71. PubMed ID: 7758562 [TBL] [Abstract][Full Text] [Related]
5. Expression of tumour necrosis factor-alpha in cryptogenic fibrosing alveolitis. Nash JR; McLaughlin PJ; Butcher D; Corrin B Histopathology; 1993 Apr; 22(4):343-7. PubMed ID: 8514277 [TBL] [Abstract][Full Text] [Related]
6. TGF-beta 1, but not TGF-beta 2 or TGF-beta 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study. Khalil N; O'Connor RN; Flanders KC; Unruh H Am J Respir Cell Mol Biol; 1996 Feb; 14(2):131-8. PubMed ID: 8630262 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical localization of transforming growth factor-beta 1 in rats with experimental silicosis, alveolar type II hyperplasia, and lung cancer. Williams AO; Flanders KC; Saffiotti U Am J Pathol; 1993 Jun; 142(6):1831-40. PubMed ID: 8389528 [TBL] [Abstract][Full Text] [Related]
8. Immunolocalization of SPARC, tenascin, and thrombospondin in pulmonary fibrosis. Kuhn C; Mason RJ Am J Pathol; 1995 Dec; 147(6):1759-69. PubMed ID: 7495300 [TBL] [Abstract][Full Text] [Related]
9. [Different cytokine profiles in usual interstitial pneumonia and nonspecific interstitial pneumonia]. Gu L; Xu WB; Liu HR; Guo ZJ; Xu XX; Zhu YJ Zhonghua Jie He He Hu Xi Za Zhi; 2003 Jun; 26(6):350-3. PubMed ID: 12899768 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical localization of transforming growth factor-beta 1 in the nonnecrotizing granulomas of pulmonary sarcoidosis. Limper AH; Colby TV; Sanders MS; Asakura S; Roche PC; DeRemee RA Am J Respir Crit Care Med; 1994 Jan; 149(1):197-204. PubMed ID: 8111583 [TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis. Egan JJ; Stewart JP; Hasleton PS; Arrand JR; Carroll KB; Woodcock AA Thorax; 1995 Dec; 50(12):1234-9. PubMed ID: 8553293 [TBL] [Abstract][Full Text] [Related]
12. Expression of glutaredoxin is highly cell specific in human lung and is decreased by transforming growth factor-beta in vitro and in interstitial lung diseases in vivo. Peltoniemi M; Kaarteenaho-Wiik R; Säily M; Sormunen R; Pääkkö P; Holmgren A; Soini Y; Kinnula VL Hum Pathol; 2004 Aug; 35(8):1000-7. PubMed ID: 15297967 [TBL] [Abstract][Full Text] [Related]
13. Cytoskeletal protein modulation in pulmonary alveolar myofibroblasts during idiopathic pulmonary fibrosis. Possible role of transforming growth factor beta and tumor necrosis factor alpha. Kapanci Y; Desmouliere A; Pache JC; Redard M; Gabbiani G Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):2163-9. PubMed ID: 8520791 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical localization of transforming growth factor-beta and insulin-like growth factor-I in asbestosis in the sheep model. Lee TC; Gold LI; Reibman J; Aston C; Bégin R; Rom WN; Jagirdar J Int Arch Occup Environ Health; 1997; 69(3):157-64. PubMed ID: 9049666 [TBL] [Abstract][Full Text] [Related]
15. Circulating antibodies to lung protein(s) in patients with cryptogenic fibrosing alveolitis. Wallace WA; Roberts SN; Caldwell H; Thornton E; Greening AP; Lamb D; Howie SE Thorax; 1994 Mar; 49(3):218-24. PubMed ID: 8202877 [TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta (TGF-beta) in silicosis. Jagirdar J; Begin R; Dufresne A; Goswami S; Lee TC; Rom WN Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):1076-81. PubMed ID: 8887610 [TBL] [Abstract][Full Text] [Related]
18. Histopathological approach to patterns of interstitial pneumonia in patient with connective tissue disorders. Nicholson AG; Colby TV; Wells AU Sarcoidosis Vasc Diffuse Lung Dis; 2002 Mar; 19(1):10-7. PubMed ID: 12002379 [TBL] [Abstract][Full Text] [Related]
19. The potential role of PDGF, IGF-1, TGF-beta expression in idiopathic pulmonary fibrosis. Cao B; Guo Z; Zhu Y; Xu W Chin Med J (Engl); 2000 Sep; 113(9):776-82. PubMed ID: 11776068 [TBL] [Abstract][Full Text] [Related]